FLI1 and metastasis: MSI−/EBV− patients with FLI1 hypermethylation in plasma samples were associated with more hematogenous metastasis and liver metastasis than those without FLI1 hypermethylation, which was not observed in MSI+ or EBV+ patients (Table 5).